- Home
- ICCM vs SACH Comparison
ICCM vs SACH Comparison
Compare ICCM & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ICCM | SACH |
|---|---|---|
| Founded | 2006 | 2010 |
| Country | Israel | United States |
| Employees | N/A | 29 |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.4M | 48.6M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | ICCM | SACH |
|---|---|---|
| Price | $0.61 | $1.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $2.50 | $2.00 |
| AVG Volume (30 Days) | ★ 169.8K | 119.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 19.42% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $19.87 | N/A |
| Revenue Next Year | $31.38 | $1.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.54 | $0.80 |
| 52 Week High | $1.53 | $1.35 |
Technical Indicators
Market Signals| Indicator | ICCM | SACH |
|---|---|---|
| Relative Strength Index (RSI) | 53.87 | 57.90 |
| Support Level | $0.59 | $1.04 |
| Resistance Level | $0.62 | $1.13 |
| Average True Range (ATR) | 0.03 | 0.02 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 68.18 | 78.57 |
Price Performance
Historical ComparisonAbout ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.